Back
ESC Professional Premium Access

Myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy.

Session: The next frontiers in innovative therapies
Topic: Cardiovascular Disease in Special Populations
Speaker: Doctor M. Desai (Cleveland, US)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)
16 presentations
0 follower

6 more presentations in this session

Discoveries to bedside therapies.

Speaker: Professor N. Dib (Phoenix, US)

Access
Slides
Video
Like
Thumbnail

Interventional solutions for heart failure.

Speaker: Professor J. Lindenfeld (Nashville, US)

Access
Slides
Video
Like
Thumbnail

Lp(a): aspirations for treating aortic stenosis.

Speaker: Professor U. Landmesser (Berlin, DE)

Access
Slides
Video
Like
Thumbnail

Can we eradicate atherosclerosis?

Speaker: Professor E. Braunwald (Boston, US)

Access
Slides
Video
Like
Thumbnail

Innovation in diagnosis and treatment of HFpEF.

Speaker: Professor I. Pina (Philadelphia, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

The next frontiers in innovative therapies

Speakers: Doctor M. Desai, Professor N. Dib, Professor J. Lindenfeld, Professor U. Landmesser, Professor E. Braunwald...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources